Austrian Pharmaceuticals & Biotech Potentially Undervalued Companies

Merck KGaA

Market Cap: €52.8b

Operates as a science and technology company in Germany and internationally.

IQVIA Holdings

Market Cap: €31.8b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Bavarian Nordic

Market Cap: €15.0b

Develops, manufactures, and supplies life-saving vaccines.

Sanofi

Market Cap: €97.1b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Recordati Industria Chimica e Farmaceutica

Market Cap: €9.7b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.

BioNTech

Market Cap: €26.8b

A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.

Bayer

Market Cap: €45.0b

Operates as a life science company worldwide.

Roche Holding

Market Cap: €284.5b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Dermapharm Holding

Market Cap: €2.0b

Manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally.

H. Lundbeck

Market Cap: €36.5b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

H. Lundbeck

Market Cap: €36.5b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

Novavax

Market Cap: €1.3b

A biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally.

Viatris

Market Cap: €16.8b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Marinomed Biotech

Market Cap: €32.4m

A biopharmaceutical company, develops therapeutic products for indications in virology and immunology in Austria, other European countries, and internationally.

Sandoz Group

Market Cap: €26.4b

Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.

Bristol-Myers Squibb

Market Cap: €126.2b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Pharma Mar

Market Cap: €1.3b

A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, China, Germany, Ireland, France, rest of the European Union, the United States, and internationally.

Pfizer

Market Cap: €154.8b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Tilray Brands

Market Cap: €883.1m

A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally.

Johnson & Johnson

Market Cap: €578.2b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

Tecan Group

Market Cap: €1.7b

Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.

Evotec

Market Cap: €1.1b

Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.

Merck

Market Cap: €302.6b

Operates as a healthcare company worldwide.

Valneva

Market Cap: €699.9m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

Thermo Fisher Scientific

Market Cap: €203.9b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

Zoetis

Market Cap: €56.2b

Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.

Eurofins Scientific

Market Cap: €12.0b

Provides various analytical testing and laboratory services worldwide.

SCHOTT Pharma KGaA

Market Cap: €2.1b

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.

Roche Holding

Market Cap: €284.5b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Novo Nordisk

Market Cap: €1.3t

Engages in the research and development, manufacture, and distribution of pharmaceutical products.

Qiagen

Market Cap: €10.5b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

Genmab

Market Cap: €120.6b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

BioMarin Pharmaceutical

Market Cap: €11.2b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Grifols

Market Cap: €6.6b

Operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.

Novartis

Market Cap: €228.9b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Ipsen

Market Cap: €11.2b

A biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience worldwide.